Vaccine efficacy based on 2 doses: Bharat Biotech after Vij tests positive ...Middle East

Business Standard - News
Vaccine efficacy based on 2 doses: Bharat Biotech after Vij tests positive
Covaxin is an indigenously developed Covid-19 vaccine undergoing a trial on over 26,000 people across 25 sites in India to evaluate the efficacy of the vaccine candidate

Hence then, the article about vaccine efficacy based on 2 doses bharat biotech after vij tests positive was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Vaccine efficacy based on 2 doses: Bharat Biotech after Vij tests positive )

Apple Storegoogle play

Last updated :

Also on site :



Latest News